233 related articles for article (PubMed ID: 28922719)
1. Baicalein as a potent neuroprotective agent: A review.
Sowndhararajan K; Deepa P; Kim M; Park SJ; Kim S
Biomed Pharmacother; 2017 Nov; 95():1021-1032. PubMed ID: 28922719
[TBL] [Abstract][Full Text] [Related]
2. [Neuroprotective effect of baicalein in patients with Parkinson's disease].
Yu X; He G; Du G
Zhongguo Zhong Yao Za Zhi; 2012 Feb; 37(4):421-5. PubMed ID: 22667137
[TBL] [Abstract][Full Text] [Related]
3. Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro.
Mu X; He G; Cheng Y; Li X; Xu B; Du G
Pharmacol Biochem Behav; 2009 Jun; 92(4):642-8. PubMed ID: 19327378
[TBL] [Abstract][Full Text] [Related]
4. Flavones from root of Scutellaria baicalensis Georgi: drugs of the future in neurodegeneration?
Gasiorowski K; Lamer-Zarawska E; Leszek J; Parvathaneni K; Yendluri BB; Błach-Olszewska Z; Aliev G
CNS Neurol Disord Drug Targets; 2011 Mar; 10(2):184-91. PubMed ID: 21222632
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of baicalein in animal models of Parkinson's disease: A systematic review of experimental studies.
Zhu Q; Zhuang X; Lu J
Phytomedicine; 2019 Mar; 55():302-309. PubMed ID: 30385133
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of Novel Baicalein Amino Acid Derivatives and Biological Evaluation as Neuroprotective Agents.
Jia X; Jia M; Yang Y; Wang D; Zhou F; Zhang W; Huang X; Guo W; Cai D; Chen H; Qi J; Zhou S; Ren H; Xu B; Ma T; Wang P; Lei H
Molecules; 2019 Oct; 24(20):. PubMed ID: 31601055
[TBL] [Abstract][Full Text] [Related]
7. Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation.
Sonawane SK; Uversky VN; Chinnathambi S
Cell Commun Signal; 2021 Feb; 19(1):16. PubMed ID: 33579328
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of baicalein against rotenone-induced neurotoxicity in PC12 cells and isolated rat brain mitochondria.
Li XX; He GR; Mu X; Xu B; Tian S; Yu X; Meng FR; Xuan ZH; Du GH
Eur J Pharmacol; 2012 Jan; 674(2-3):227-33. PubMed ID: 21996316
[TBL] [Abstract][Full Text] [Related]
9. Effect of baicalein from Scutellaria baicalensis on prevention of noise-induced hearing loss.
Kang TH; Hong BN; Park C; Kim SY; Park R
Neurosci Lett; 2010 Jan; 469(3):298-302. PubMed ID: 20004700
[TBL] [Abstract][Full Text] [Related]
10. Baicalein Protects against Rotenone-Induced Neurotoxicity through Induction of Autophagy.
Kuang L; Cao X; Lu Z
Biol Pharm Bull; 2017 Sep; 40(9):1537-1543. PubMed ID: 28659545
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease.
Li Y; Zhao J; Hölscher C
CNS Drugs; 2017 Aug; 31(8):639-652. PubMed ID: 28634902
[TBL] [Abstract][Full Text] [Related]
12. Baicalein alleviates depression-like behavior in rotenone- induced Parkinson's disease model in mice through activating the BDNF/TrkB/CREB pathway.
Zhao X; Kong D; Zhou Q; Wei G; Song J; Liang Y; Du G
Biomed Pharmacother; 2021 Aug; 140():111556. PubMed ID: 34087694
[TBL] [Abstract][Full Text] [Related]
13. Baicalein exerts anti-neuroinflammatory effects to protect against rotenone-induced brain injury in rats.
Zhang X; Yang Y; Du L; Zhang W; Du G
Int Immunopharmacol; 2017 Sep; 50():38-47. PubMed ID: 28623717
[TBL] [Abstract][Full Text] [Related]
14. Baicalein inhibits formation of α-synuclein oligomers within living cells and prevents Aβ peptide fibrillation and oligomerisation.
Lu JH; Ardah MT; Durairajan SS; Liu LF; Xie LX; Fong WF; Hasan MY; Huang JD; El-Agnaf OM; Li M
Chembiochem; 2011 Mar; 12(4):615-24. PubMed ID: 21271629
[TBL] [Abstract][Full Text] [Related]
15. The effect of Baicalein on hippocampal neuronal damage and metalloproteinase activity following transient global cerebral ischaemia.
Lee JH; Lee SR
Phytother Res; 2012 Nov; 26(11):1614-9. PubMed ID: 22344890
[TBL] [Abstract][Full Text] [Related]
16. Ameliorative effects of baicalein on an amyloid-β induced Alzheimer's disease rat model: a proteomics study.
Wei D; Tang J; Bai W; Wang Y; Zhang Z
Curr Alzheimer Res; 2014; 11(9):869-81. PubMed ID: 25274114
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of baicalein against excess L-DOPA-induced dopamine quinone neurotoxicity.
Takeshima M; Murata M; Urasoe N; Murakami S; Miyazaki I; Asanuma M; Kita T
Neurol Res; 2011 Dec; 33(10):1050-6. PubMed ID: 22196758
[TBL] [Abstract][Full Text] [Related]
18. In silico target fishing for the potential targets and molecular mechanisms of baicalein as an antiparkinsonian agent: discovery of the protective effects on NMDA receptor-mediated neurotoxicity.
Gao L; Fang JS; Bai XY; Zhou D; Wang YT; Liu AL; Du GH
Chem Biol Drug Des; 2013 Jun; 81(6):675-87. PubMed ID: 23461900
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile.
Cheng Y; He G; Mu X; Zhang T; Li X; Hu J; Xu B; Du G
Neurosci Lett; 2008 Aug; 441(1):16-20. PubMed ID: 18586394
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of microglial activation by the herbal flavonoid baicalein attenuates inflammation-mediated degeneration of dopaminergic neurons.
Li FQ; Wang T; Pei Z; Liu B; Hong JS
J Neural Transm (Vienna); 2005 Mar; 112(3):331-47. PubMed ID: 15503194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
